Empire Financial Management Company LLC Has $1.98 Million Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Empire Financial Management Company LLC raised its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.2% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 20,007 shares of the exchange traded fund’s stock after acquiring an additional 629 shares during the period. Empire Financial Management Company LLC’s holdings in SPDR S&P Biotech ETF were worth $1,977,000 at the end of the most recent quarter.

A number of other institutional investors have also recently modified their holdings of XBI. Continuum Advisory LLC boosted its position in shares of SPDR S&P Biotech ETF by 4.5% during the 3rd quarter. Continuum Advisory LLC now owns 33,029 shares of the exchange traded fund’s stock worth $3,202,000 after acquiring an additional 1,433 shares in the last quarter. Nomura Asset Management Co. Ltd. acquired a new position in SPDR S&P Biotech ETF during the third quarter valued at approximately $1,442,000. Headinvest LLC lifted its stake in SPDR S&P Biotech ETF by 8.2% during the third quarter. Headinvest LLC now owns 4,762 shares of the exchange traded fund’s stock worth $470,000 after purchasing an additional 362 shares during the last quarter. National Bank of Canada FI boosted its holdings in shares of SPDR S&P Biotech ETF by 11.0% in the 3rd quarter. National Bank of Canada FI now owns 15,986 shares of the exchange traded fund’s stock valued at $1,579,000 after purchasing an additional 1,589 shares in the last quarter. Finally, Castleark Management LLC increased its stake in shares of SPDR S&P Biotech ETF by 130.7% in the 3rd quarter. Castleark Management LLC now owns 115,580 shares of the exchange traded fund’s stock valued at $11,419,000 after purchasing an additional 65,490 shares during the last quarter.

SPDR S&P Biotech ETF Stock Down 0.8 %

Shares of XBI stock opened at $97.42 on Wednesday. The business has a fifty day simple moving average of $98.20 and a 200 day simple moving average of $97.00. The company has a market cap of $7.43 billion, a P/E ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a twelve month low of $77.50 and a twelve month high of $105.47.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.